Substance use disorders - principles of the neurobiology of addiction and tolerance

The shared pathway

Addiction across different substances converges on a shared neurobiological final pathway - dysregulated mesolimbic dopamine reward signalling - despite each substance class acting through a different initial receptor mechanism (opioid receptors, GABA/glutamate systems, dopamine transporter blockade, and others), explaining why addiction shares common behavioural features across very different substances
Foundational neuroscience underlying understanding of why addiction develops and why it is characterised as a chronic brain disease rather than simply a behavioural choice

Repeated substance-induced dopamine surges in the mesolimbic reward pathway drive progressively stronger drug-associated learning and craving, while chronic exposure causes neuroadaptive changes (reduced baseline dopamine receptor sensitivity, altered prefrontal cortex regulatory control) that together explain the core addiction features - tolerance (needing more for the same effect), craving, and impaired control over use despite negative consequences

Not directly tested via a specific investigation, but this neurobiological framework explains observed clinical phenomena (cross-tolerance between substances acting on related pathways, the chronic relapsing course, and why willpower-based approaches alone are often insufficient given the underlying neuroadaptive changes)
Understanding addiction as a neurobiological disease (not purely a moral/willpower issue) supports evidence-based pharmacotherapy use and reduces stigma-driven under-treatment
Explains the rationale for agonist substitution treatments (methadone, buprenorphine) - providing controlled, stable receptor occupation reduces the compulsive drug-seeking driven by fluctuating, unpredictable receptor activation from illicit use

Prefrontal cortex impaired regulatory control (explaining impaired control over use despite consequences), cross-tolerance between substances sharing pathway mechanisms, opioid agonist treatment's neurobiological rationale, dopamine reward pathway as the shared final common pathway

Addiction's neurobiological basis - convergent dysregulation of the mesolimbic dopamine reward pathway despite different substances acting through entirely different initial receptor mechanisms - is why addiction is understood as a chronic brain disease with predictable, treatable neurobiological features, not simply a matter of insufficient willpower, supporting the case for evidence-based medical treatment rather than a purely punitive or moralistic response

4 more sections, plus exam facts

Premium unlocks every note across every specialty, and the full exam fact library behind it.